Company Encyclopedia
View More
name
IMIC
000516.SZ
Xi'an International Medical Investment Company Limited provides healthcare services. It operates hospitals and medical centers. It also engages in insurance broking, tourism, and pharmaceutical production business. Xi'an International Medical Investment Company Limited was formerly known as Xi’an Kaiyuan Investment Group Co., Ltd.
173.94 B
000516.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Health Care FacilitiesIndustry
Industry Ranking7/9
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-9.60%D
    • Profit Margin-7.98%D
    • Gross Margin4.90%E
  • Growth ScoreD
    • Revenue YoY-13.85%E
    • Net Profit YoY6.27%C
    • Total Assets YoY-7.23%D
    • Net Assets YoY-12.20%E
  • Cash ScoreE
    • Cash Flow Margin-1252.59%E
    • OCF YoY-13.85%E
  • Operating ScoreC
    • Turnover0.41C
  • Debt ScoreD
    • Gearing Ratio68.80%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The Director of the Department of Health, Lin Wenjian, attended the 2025 Capital International Medical Conference in Beijing to introduce the development of medical innovation in Hong Kong

    The Director of the Department of Health, Lin Wenjian, attended the 2025 Capital International Medical Conference in Beijing, emphasizing Hong Kong's medical innovation and development. In response to challenges such as an aging population and technological advancements, Hong Kong will establish the "Hong Kong Drug and Medical Device Regulatory Center" and implement a new drug registration mechanism to promote the development of the local medical and biotechnology industry. The delegation held in-depth discussions with Chinese health authorities on public health issues and signed a cooperation agreement

    AASTOCKS·
    SZ
    000516
    +0.64%
    AASTOCKS·
    SZ
    000516
    +0.64%

    Beijing has a total of 12,000 medical institutions, and pharmaceutical innovation will strengthen the application of artificial intelligence technology

    The Capital International Medical Conference was held on the 13th at the Service Trade Fair. At the press conference, it was learned that Beijing's medical service capacity continues to grow, with a total of 12,000 medical institutions in the city providing difficult and critical illness treatment services nationwide. Beijing's medical innovation resources are continuously enriched, with 13 national medical centers across 12 categories, 23 national clinical research centers, 335 national key specialty construction projects, and several new research and development institutions

    Zhitong·
    SZ
    000516
    +0.64%
    Zhitong·
    SZ
    000516
    +0.64%

    International Medical: The medical institutions under its umbrella have introduced a rehabilitation training system that combines brain-machine interfaces with functional electrical stimulation and other related rehabilitation equipment to carry out surgeries such as deep brain stimulation

    IMIC stated on the interactive platform that in order to serve patients, the medical institutions under the company have introduced rehabilitation training systems that combine brain-machine interfaces with exoskeleton robots or functional electrical stimulation and have carried out related surgeries such as deep brain stimulation surgery, spinal nerve stimulation surgery, and vagus nerve stimulation surgery

    Zhitong·
    SZ
    000516
    +0.64%
    Zhitong·
    SZ
    000516
    +0.64%

    IMIC: Expected net profit loss of 160 million to 170 million yuan in the first half of the year

    International Medical announced that it expects its operating revenue for the first half of 2025 to be between 2.01 billion and 2.05 billion yuan, compared to 2.42 billion yuan in the same period last year; it expects a net profit loss of 170 million to 160 million yuan for the first half of 2025, compared to a loss of 174 million yuan in the same period last year

    Zhitong·
    SZ
    000516
    +0.64%
    Zhitong·
    SZ
    000516
    +0.64%

    IMIC: The controlling shareholder Century New Yuan has lifted the pledge on 32.44 million shares

    On July 9th, International Medical announced that its controlling shareholder, Century New Yuan, recently completed the release of part of its pledged shares. The number of shares released from pledge is 32.44 million shares, accounting for 5.27% of its held shares and 1.45% of the company's total share capital. As of the announcement date, Century New Yuan and its concerted parties have a total of 46.932 million pledged shares, accounting for 65.31% of its held shares and 20.96% of the company's total share capital

    Zhitong·
    SZ
    000516
    +0.64%
    Zhitong·
    SZ
    000516
    +0.64%
    © 2025 Longbridge｜Disclaimer